Literature DB >> 22427411

Mucocutaneous leishmaniasis in a patient treated with anti-TNF-α therapy.

Estrella Garcia-Gonzalez, Giacomo M Guidelli, Marco Bardelli, Roberta Maggio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22427411     DOI： 10.1093/rheumatology/kes030

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  TNF deficiency dysregulates inflammatory cytokine production, leading to lung pathology and death during respiratory poxvirus infection.

Authors:  Ma Junaliah Tuazon Kels; Esther Ng; Zahrah Al Rumaih; Pratikshya Pandey; Sigrid R Ruuls; Heinrich Korner; Timothy P Newsome; Geeta Chaudhri; Gunasegaran Karupiah
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

2.  Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression.

Authors:  Pau Bosch-Nicolau; Maria Ubals; Fernando Salvador; Adrián Sánchez-Montalvá; Gloria Aparicio; Alba Erra; Pablo Martinez de Salazar; Elena Sulleiro; Israel Molina
Journal:  PLoS Negl Trop Dis       Date:  2019-08-30

3.  Case Report: Unusual Presentation of Pharyngeal Mucosal Leishmaniasis due to Leishmania (Viannia) braziliensis.

Authors:  Lorena Pinheiro Figueiredo; Laiana do Carmo Almeida; Andréa Magalhães; Sérgio Arruda; Marcus M Lessa; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.